Literature DB >> 24564738

ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristics.

Hiroshi Mitsumoto1, Pam Factor-Litvak, Howard Andrews, Raymond R Goetz, Leslie Andrews, Judith G Rabkin, Martin McElhiney, Jeri Nieves, Regina M Santella, Jennifer Murphy, Jonathan Hupf, Jess Singleton, David Merle, Mary Kilty, Daragh Heitzman, Richard S Bedlack, Robert G Miller, Jonathan S Katz, Dallas Forshew, Richard J Barohn, Eric J Sorenson, Bjorn Oskarsson, J Americo M Fernandes Filho, Edward J Kasarskis, Catherine Lomen-Hoerth, Tahseen Mozaffar, Yvonne D Rollins, Sharon P Nations, Andrea J Swenson, Jeremy M Shefner, Jinsy A Andrews, Boguslawa A Koczon-Jaremko.   

Abstract

Abstract In a multicenter study of newly diagnosed ALS patients without a reported family history of ALS, we are prospectively investigating whether markers of oxidative stress (OS) are associated with disease progression. Methods utilize an extensive structured telephone interview ascertaining environmental, lifestyle, dietary and psychological risk factors associated with OS. Detailed assessments were performed at baseline and at 3-6 month intervals during the ensuing 30 months. Our biorepository includes DNA, plasma, urine, and skin. Three hundred and fifty-five patients were recruited. Subjects were enrolled over a 36-month period at 16 sites. To meet the target number of subjects, the recruitment period was prolonged and additional sites were included. Results showed that demographic and disease characteristics were similar between 477 eligible/non-enrolled and enrolled patients, the only difference being type of health insurance among enrolled patients. Sites were divided into three groups by the number of enrolled subjects. Comparing these three groups, the Columbia site had fewer 'definite ALS' diagnoses. This is the first prospective, interdisciplinary, in-depth, multicenter epidemiological investigation of OS related to ALS progression and has been accomplished by an aggressive recruitment process. The baseline demographic and disease features of the study sample are now fully characterized.

Entities:  

Keywords:  ALS; disease progression; epidemiology; oxidative stress; survival

Mesh:

Year:  2014        PMID: 24564738      PMCID: PMC4310702          DOI: 10.3109/21678421.2013.864312

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  81 in total

1.  Measuring pseudobulbar affect in ALS.

Authors:  Richard A Smith; James E Berg; Laura E Pope; Ronald A Thisted
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2004-09

2.  Visual analogue scales: measurement of subjective phenomena.

Authors:  A G Gift
Journal:  Nurs Res       Date:  1989 Sep-Oct       Impact factor: 2.381

3.  Evaluation of two food frequency methods of measuring dietary calcium intake.

Authors:  S R Cummings; G Block; K McHenry; R B Baron
Journal:  Am J Epidemiol       Date:  1987-11       Impact factor: 4.897

4.  Development and validation of brief measures of positive and negative affect: the PANAS scales.

Authors:  D Watson; L A Clark; A Tellegen
Journal:  J Pers Soc Psychol       Date:  1988-06

5.  The measurement of pessimism: the hopelessness scale.

Authors:  A T Beck; A Weissman; D Lester; L Trexler
Journal:  J Consult Clin Psychol       Date:  1974-12

Review 6.  Live events, stress, and illness.

Authors:  J G Rabkin; E L Struening
Journal:  Science       Date:  1976-12-03       Impact factor: 47.728

7.  A reduced dietary questionnaire: development and validation.

Authors:  G Block; A M Hartman; D Naughton
Journal:  Epidemiology       Date:  1990-01       Impact factor: 4.822

8.  Evaluation of a brief telephone questionnaire to estimate fruit and vegetable consumption in diverse study populations.

Authors:  M Serdula; R Coates; T Byers; A Mokdad; S Jewell; N Chávez; J Mares-Perlman; P Newcomb; C Ritenbaugh; F Treiber
Journal:  Epidemiology       Date:  1993-09       Impact factor: 4.822

9.  Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study.

Authors:  T Zaldivar; J Gutierrez; G Lara; M Carbonara; G Logroscino; O Hardiman
Journal:  Neurology       Date:  2009-05-12       Impact factor: 9.910

View more
  18 in total

Review 1.  Potential Environmental Factors in Amyotrophic Lateral Sclerosis.

Authors:  Björn Oskarsson; D Kevin Horton; Hiroshi Mitsumoto
Journal:  Neurol Clin       Date:  2015-11       Impact factor: 3.806

2.  Cognitive impairment, behavioral impairment, depression, and wish to die in an ALS cohort.

Authors:  Judith Rabkin; Raymond Goetz; Jennifer Mary Murphy; Pam Factor-Litvak; Hiroshi Mitsumoto
Journal:  Neurology       Date:  2016-08-05       Impact factor: 9.910

3.  Plasma creatinine and oxidative stress biomarkers in amyotrophic lateral sclerosis.

Authors:  Hiroshi Mitsumoto; Diana C Garofalo; Regina M Santella; Eric J Sorenson; Björn Oskarsson; J Americo M Fernandes; Howard Andrews; Jonathan Hupf; Madison Gilmore; Daragh Heitzman; Richard S Bedlack; Jonathan S Katz; Richard J Barohn; Edward J Kasarskis; Catherine Lomen-Hoerth; Tahseen Mozaffar; Sharon P Nations; Andrea J Swenson; Pam Factor-Litvak
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2020-04-10       Impact factor: 4.092

4.  Outcome measures in amyotrophic lateral sclerosis clinical trials.

Authors:  Sabrina Paganoni; Merit Cudkowicz; James D Berry
Journal:  Clin Investig (Lond)       Date:  2014

5.  Population-based surveillance of amyotrophic lateral sclerosis in New Jersey, 2009-2011.

Authors:  Heather Jordan; Jerald Fagliano; Lindsay Rechtman; Daniel Lefkowitz; Wendy Kaye
Journal:  Neuroepidemiology       Date:  2014-10-16       Impact factor: 3.282

6.  Depression and wish to die in a multicenter cohort of ALS patients.

Authors:  Judith G Rabkin; Raymond Goetz; Pam Factor-Litvak; Jonathan Hupf; Martin McElhiney; Jessica Singleton; Hiroshi Mitsumoto
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-12-08       Impact factor: 4.092

7.  Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort.

Authors:  Jennifer Murphy; Pam Factor-Litvak; Raymond Goetz; Catherine Lomen-Hoerth; Peter L Nagy; Jonathan Hupf; Jessica Singleton; Susan Woolley; Howard Andrews; Daragh Heitzman; Richard S Bedlack; Jonathan S Katz; Richard J Barohn; Eric J Sorenson; Björn Oskarsson; J Americo M Fernandes Filho; Edward J Kasarskis; Tahseen Mozaffar; Yvonne D Rollins; Sharon P Nations; Andrea J Swenson; Boguslawa A Koczon-Jaremko; Hiroshi Mitsumoto
Journal:  Neurology       Date:  2016-01-22       Impact factor: 9.910

8.  Association Between Dietary Intake and Function in Amyotrophic Lateral Sclerosis.

Authors:  Jeri W Nieves; Chris Gennings; Pam Factor-Litvak; Jonathan Hupf; Jessica Singleton; Valerie Sharf; Björn Oskarsson; J Americo M Fernandes Filho; Eric J Sorenson; Emanuele D'Amico; Ray Goetz; Hiroshi Mitsumoto
Journal:  JAMA Neurol       Date:  2016-12-01       Impact factor: 18.302

9.  Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders.

Authors:  Estela Area-Gomez; H Mitsumoto; D Larrea; T Yun; Y Xu; J Hupf; F Zandkarimi; R B Chan
Journal:  Sci Rep       Date:  2021-06-30       Impact factor: 4.379

Review 10.  Upper Motor Neuron Disorders: Primary Lateral Sclerosis, Upper Motor Neuron Dominant Amyotrophic Lateral Sclerosis, and Hereditary Spastic Paraplegia.

Authors:  Timothy Fullam; Jeffrey Statland
Journal:  Brain Sci       Date:  2021-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.